🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the effect of setanaxib ...
Status
Completed
Location
UA Thomas D. Boyer Liver Institute
Start Date
2022-02-14
Trial ID
NCT05014672
The purpose of this study is to assess the safety and efficacy of GKT13783 ...
Status
Completed
Location
Mayo Clinic
Start Date
2017-06-26
Trial ID
NCT03226067
Treatments Being Tested
The purpose of the study is to learn about the safety and tolerability of s...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2023-11-27
Trial ID
NCT06274489
The study will be a comparative oral bioavailability study between GKT13783...
Status
Completed
Location
Eurofins Optimed
Start Date
2018-12-19
Trial ID
NCT03740217
Treatments Being Tested
The primary objective of this study is to compare the change in tumour size...
Status
Completed
Location
Mount Sinai Comprehensive Cancer Center
Start Date
2022-04-06
Trial ID
NCT05323656
Treatments Being Tested
The study is a monocentric, open label, phase 1 study to evaluate the pharm...
Status
Completed
Location
Eurofins Optimed
Start Date
2020-06-24
Trial ID
NCT04327089
Treatments Being Tested
NADPH oxidase enzymes (NOX) have been implicated in the development of seve...
Status
Completed
Location
Advanced Arizona Clinical Research
Start Date
2013-10
Trial ID
NCT02010242
A placebo-controlled, multicenter, randomized trial to test GKT137831 in am...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-09-07
Trial ID
NCT03865927
Treatments Being Tested